Method for tagging material with surface-enhanced spectroscopy (SES)-active composite nanoparticles
US-9201013-B2 · Dec 1, 2015 · US
US9677075B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9677075-B2 |
| Application number | US-201414786569-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 23, 2014 |
| Priority date | Apr 23, 2013 |
| Publication date | Jun 13, 2017 |
| Grant date | Jun 13, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are metal-ligand complexes containing polynucleotides, compounds for making the same, and methods of using the same.
Opening claim text (preview).
What is claimed: 1. A compound having a structure: wherein R is OH or —O—C(O)—NAr 2 , each Ar is aryl, and n is 1 or 2. 2. The compound of claim 1 , wherein n is 1 and the pyridone moiety is attached to the phenyl at the para position. 3. The compound of claim 1 , wherein n is 2 and the pyridone moieties are attached to the phenyl at the meta positions. 4. A polynucleotide comprising at a terminus a moiety comprising: wherein R is OH or —O—C(O)—NAr 2 , each Ar is aryl, n is 1 or 2, and Alkylene comprises 6-20 carbons. 5. The polynucleotide of claim 4 , wherein n is 1 and the pyridone moiety is attached to the phenyl at the para position. 6. The polynucleotide of claim 4 , wherein n is 2 and the pyridone moieties are attached to the phenyl at the meta positions. 7. A metal-ligand complex comprising the polynucleotide of claim 4 and iron (III). 8. A supramolecular complex comprising a first metal-ligand complex of claim 7 and a second metal-ligand complex of claim 7 , wherein the first metal-ligand complex comprises a first polynucleotide and the second metal-ligand complex comprises a second polynucleotide that is sufficiently complementary to the first polynucleotide to hybridize under appropriate conditions. 9. A method of inhibiting expression of a gene product encoded by a target polynucleotide comprising contacting the target polynucleotide with the supramolecular complex of claim 8 under conditions sufficient to inhibit expression of the gene product.
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids · CPC title
Nanoparticles · CPC title
Compounds having three or more nucleosides or nucleotides · CPC title
involving nucleic acids · CPC title
Iron compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.